−1.30TWD
−47.35 MTWD
231.83 MTWD
About LUKAS BIOMEDICAL INC
Sector
Industry
CEO
Chao An Liu
Website
Headquarters
Taipei
Employees (FY)
88
Founded
2013
ISIN
TW0006814007
FIGI
BBG00YPHS9K8
Lukas Biomedical, Inc. engages in the lease and sale of medical equipment. It operates through the Electronic Commerce and Medical Management segments. It also offers biotechnology beauty products and immune cell therapy. The company was founded on December 26, 2013 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6814 is 29.80 TWD — it has increased by 0.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange LUKAS BIOMEDICAL INC stocks are traded under the ticker 6814.
6814 stock is 0.00% volatile and has beta coefficient of 0.17. Check out the list of the most volatile stocks — is LUKAS BIOMEDICAL INC there?
Yes, you can track LUKAS BIOMEDICAL INC financials in yearly and quarterly reports right on TradingView.
6814 stock has risen by 0.00% compared to the previous week, the month change is a 2.41% fall, over the last year LUKAS BIOMEDICAL INC has showed a 20.66% decrease.
6814 net income for the last quarter is −32.65 M TWD, while the quarter before that showed −14.71 M TWD of net income which accounts for −122.02% change. Track more LUKAS BIOMEDICAL INC financial stats to get the full picture.
No, 6814 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6814 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUKAS BIOMEDICAL INC stock right from TradingView charts — choose your broker and connect to your account.
As of May 2, 2024, the company has 88.00 employees. See our rating of the largest employees — is LUKAS BIOMEDICAL INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LUKAS BIOMEDICAL INC technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LUKAS BIOMEDICAL INC stock shows the sell signal. See more of LUKAS BIOMEDICAL INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LUKAS BIOMEDICAL INC EBITDA is −11.93 M TWD, and current EBITDA margin is −5.15%. See more stats in LUKAS BIOMEDICAL INC financial statements.